Various polysiloxanes bearing chlorobenzyl side groups were synthesized by the hydrolytic polycondensation of the 73:27 mol/mol mixture of [2‐(4‐chloromethylphenyl)ethyl] methyldichlorosilane and [1‐(4‐chloromethylphenyl)ethyl] methyldichlorosilane followed by the cationic equilibration or coequilibration with octamethylcyclotetrasiloxane, D4. 1,3‐Divinyltetramethyl‐disiloxane was used as the chain end blocker to obtain a vinyl–Si ended chlorobenzyl‐substituted polysiloxane. In some cases, the polymer was additionally treated with dimethylvinylchlorosilane to achieve full substitution of chain ends by the vinyl group. Cohydrolysis of the chlorobenzylic monomer mixture with dimethyldichlorosilane was also practiced. Multiblock copolymers were obtained by polyhydrosilylation of the α,ω‐divinylsilyl chlorobenzyl‐substituted polysiloxanes with α,ω‐dihydrosilyl polydimethylsiloxanes. All these polymers and copolymers containing reactive chlorobenzylic groups were demonstrated to be convenient precursors of functional polysiloxanes of potential practical use. Some specific functional groups, such as quaternary ammonium salt groups of biocidal activity or azobenzene groups making the polymer sensitive to external stimuli by light, may be readily generated on polysiloxane under mild conditions. The chlorobenzylic substituted polysiloxanes may be also used as macroinitiators of the atom transfer radical polymerization, to obtain polysiloxanes with grafted organic polymers, such as styrene, 4‐chloromethylstyrene, and n‐butylacrylate.
No takes yet. Share an insight, caveat, or question.
Kaźmierski et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: